HSandM Magazine

Menu
  • Home
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
  • Advertise
  • Agency Directory
  • Showcase your Innovations
  • FREE SUBSCRIPTION!
Menu

HSandM Magazine

Search

Mar/Apr2015

Latest stories

OUR PROMISE

Top 9 Ways to Make Your Exhibit Program Work As Hard As You Do

A-DATE: A GUIDE TO CHOOSING AN AGENCY

More stories

  • in Uncategorized

    How Do Physicians Influence OTC Purchases?

    by hsandm March 1, 2015, 12:00 pm

  • in Round Table

    RX FOR AGENCIES

    by hsandm March 1, 2015, 12:00 pm

  • in Industry Trends

    BY THE NUMBERS

  • in Innovation Showcase

    Hearts and Minds… but Mostly Hearts

    by hsandm March 1, 2015, 12:00 pm

  • in Top Industry Lists

    HS & M TOP 50 BIOTECH COMPANIES

    by hsandm March 1, 2015, 12:00 pm

  • in Motivideos

    MOTIVATION

    by hsandm March 1, 2015, 12:00 pm

  • in Industry Trends

    THE EYEFORPHARMA PHILADELPHIA AWARDS FINALISTS

    by hsandm March 1, 2015, 12:00 pm

  • in Industry Trends

    Patient Education Innovation

    by hsandm March 1, 2015, 12:00 pm

  • in Motivideos

    MOTIVIDEOS

Trending Now

  • 872 Views0 Comments

    in Headlines

    Backed by Bayer, Senti Biosciences Snags $105 Million in Series B Fundraising

    Leverkusen, Germany & South San Francisco, CA, January 6 2021 (Business Wire) — Leaps by Bayer and Senti Biosciences, Inc., a leading gene circuit company, today announced a USD 105 million Series B financing round. The financing was led by Leaps by Bayer, the impact investment arm of Bayer AG. Additional investors included Matrix Partners China, Mirae Asset Capital, Ridgeback Capital and Intel Capital as well as existing investors, including New Enterprise Associates (NEA), 8VC, Amgen Ventures and Lux Capital. More

    by hsandm January 6, 2021, 10:15 pm

    Read More

  • 1 Shares670 Views0 Comments

    in Headlines

    Biomarck Appoints Graham Lumsden as President and Chief Executive Officer

    Durham, NC, January 6 2021 (Business Wire) — Biomarck Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company developing anti-inflammatory and oncological therapies that target the MARCKS protein, today announced the appointment of Dr. Graham G. Lumsden as President and Chief Executive Officer. More

    by hsandm January 6, 2021, 9:59 pm

    Read More

  • 724 Views0 Comments

    in Headlines

    Ribometrix and Genentech Partner in Potential $1Billion+ RNA Deal

    Durham, NC, January 6 2021 (Business Wire) — Ribometrix, Inc. today announced a strategic collaboration with Genentech, a member of the Roche Group, to discover and develop novel RNA-targeted small molecule therapeutics against several targets.
    Ribometrix is focused on leveraging its RNA structural expertise and analytical capabilities to make the vast landscape of RNA, which is involved in a wide variety of disease processes, accessible to small molecule therapeutics
    More

    by hsandm January 6, 2021, 9:51 pm

    Read More

  • 1.1k Views0 Comments

    in Headlines

    Artiva Biotherapeutics Announces Appointment of Dr. Fred Aslan as President and CEO

    San Diego, CA, January 5 2021 (Bloomberg) — Artiva Biotherapeutics, Inc., an oncology company focused on developing and commercializing primary allogeneic natural killer (NK) cell therapies to treat cancer, announced today the appointment of Fred Aslan, M.D., as President and Chief Executive Officer. Dr. Aslan brings a twenty-year track record as an executive and investor in the life sciences industry. More

    by hsandm January 5, 2021, 9:39 pm

    Read More

  • 623 Views0 Comments

    in Headlines

    Hologic to Acquire Biotheranostics, Leader in Molecular Tests for Breast and Metastatic Cancers, for Approximately $230 Million

    Marlborough, MA , January 5 2021 (Business Wire) — Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing adjustments. More

    by hsandm January 5, 2021, 9:27 pm

    Read More

  • 1.3k Views0 Comments

    in Talent Trends

    The Instant-On, On-Demand Workforce

    How have the pandemic, IT advances, remote working, skill set requirements and other influences in these fast-changing times affected our strategies and practices in hiring? Quite a lot, and it’s the responsibility of every company to keep up with the needs and opportunities that are before us. In addition, how do we deal with the […] More

    by hsandm December 22, 2020, 2:43 am

    Read More

Categories

  • Agency Directory
  • Digital Magazine
  • Editorial Board
  • Executive Spotlight
  • Great Minds
  • Headlines
  • Industry Trends
  • Innovation Showcase
  • Leadership
  • Motivideos
  • Round Table
  • Talent Trends
  • Top Industry Lists
  • Uncategorized
  • Why I Work in Healthcare

© 2021 by CL Media, Inc.

  • Home
  • Contact us
  • GDPR Privacy policy
  • Privacy Policy
  • Terms of Use
  • Sign Up!
Back to Top
Close
  • Home
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
  • Advertise
  • Agency Directory
  • Showcase your Innovations
  • FREE SUBSCRIPTION!
  • facebook
  • twitter
  • instagram
  • pinterest
  • youtube

Log In

Sign In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.